Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (19995)	3/22/1999 11:55:00 PM
From: VLAD	Respond to of 23519

This article is old but I don't remember anyone ever posting it: ncbi.nlm.nih.gov Note that Dr Padmypocket was involved in this study. Seemed to me as if he gave Vivus the cold shoulder after his initial involvement in the phase III clinical trials of MUSE. Vivus probably padded his pockets again and thus another article with his name on it. I don't know if he or his cohort Goldstein disgust me the most. IMO they both have a license to steal.....that is the money of any company involved in ED product development that they are paid to tout.